The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...

qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a new ...

Hormel Foods recalled 256,000 pounds of canned beef stew due to potential contamination with wood fragments. ( CBS News) ...

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending drug abiraterone, in clinical trial results presented by scientists from ...

Nigam Shah, CDO for Stanford Health Care, explains how Microsoft's multiagent orchestration technology enables the management ...

The test could help direct prostate cancer patients to the best treatment option for them, researchers behind the findings ...

Scientists say they have worked out a machine learning method with the ability to provide close to precise survival estimates of patients afflicted ...

A powerful new ally is emerging in cancer care: artificial intelligence (AI). In the ever-evolving landscape of prostate ...

FaceAge aims to predict biological age using AI, and links facial appearance with survival rates in cancer patients.